Evaluating cardiac imaging techniques for heart diseases
Novel Magnetic Resonance Imaging Techniques for Quantitative Cardiac Parametric Mapping
This study is testing new heart imaging techniques to see if they can help doctors better diagnose and treat people with different heart diseases.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 240 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Medical University of South Carolina Academic / other |
| Locations | 1 site (Charleston, South Carolina) |
| Trial ID | NCT02855554 on ClinicalTrials.gov |
What this trial studies
This project aims to assess the clinical potential of advanced cardiac magnetic resonance imaging (CMR) techniques for the quantitative characterization of myocardial tissue. It focuses on aiding the diagnosis, treatment, and follow-up of patients with various myocardial diseases, including ischemic heart disease, cardiomyopathy, and myocarditis. By utilizing fast CMR imaging, the study seeks to improve the understanding of heart conditions and enhance patient care.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18-90 who have been diagnosed with or are suspected to have myocardial ischemia, cardiomyopathy, or myocarditis.
Not a fit: Patients with implanted devices contraindicated for MRI, acute psychiatric disorders, or those in unstable conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate diagnoses and better treatment strategies for patients with myocardial diseases.
How similar studies have performed: Other studies utilizing advanced cardiac imaging techniques have shown promise in improving diagnostic accuracy and patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject must be 18-90 years of age. * Subject must be previously diagnosed with or suspected to have one of the following conditions. * Myocardial ischemia or infarction (group 1) * Hypertrophic cardiomyopathy (group 2) * Infiltrative cardiomyopathy (group 3) * Myocarditis (group 4) * Subject must have been referred for a clinically indicated CMR. Exclusion Criteria: * Subject has any implanted device or condition in which an MR scan would be contraindicated. * Subject has an acute psychiatric disorder or is cognitively impaired. * Subject is using or is dependent on substances of abuse. * Subject is unwilling to comply with the requirements of the protocol. * Subject has previously entered this study. * Subject has an allergy against MRI contrast agents. * Subject is in acute unstable condition.
Where this trial is running
Charleston, South Carolina
- Medical University of South Carolina — Charleston, South Carolina, United States (Recruiting)
Study contacts
- Principal investigator: Akos Varga-Szemes, MD — Medical University of South Carolina
- Study coordinator: Mark Ghent, BA
- Email: ghent@musc.edu
- Phone: 843-876-7148
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.